Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Tango Therapeutics (TNGX) Tax Provisions (2020 - 2025)

Historic Tax Provisions for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to -$10000.0.

  • Tango Therapeutics' Tax Provisions fell 11851.85% to -$10000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $67000.0, marking a year-over-year decrease of 6528.5%. This contributed to the annual value of $208000.0 for FY2024, which is 5522.39% up from last year.
  • As of Q3 2025, Tango Therapeutics' Tax Provisions stood at -$10000.0, which was down 11851.85% from $35000.0 recorded in Q2 2025.
  • Tango Therapeutics' 5-year Tax Provisions high stood at $185000.0 for Q4 2021, and its period low was -$21000.0 during Q2 2021.
  • Over the past 5 years, Tango Therapeutics' median Tax Provisions value was $37500.0 (recorded in 2024), while the average stood at $48937.5.
  • Its Tax Provisions has fluctuated over the past 5 years, first skyrocketed by 323333.33% in 2023, then plummeted by 11851.85% in 2025.
  • Tango Therapeutics' Tax Provisions (Quarter) stood at $185000.0 in 2021, then plummeted by 47.57% to $97000.0 in 2022, then tumbled by 64.95% to $34000.0 in 2023, then crashed by 76.47% to $8000.0 in 2024, then tumbled by 225.0% to -$10000.0 in 2025.
  • Its last three reported values are -$10000.0 in Q3 2025, $35000.0 for Q2 2025, and $34000.0 during Q1 2025.